Inactivation of PI3K-C2α deregulates cell death pathways and sensitizes to endotoxic shock.
Summary
Genetic inactivation of PI3K-C2α in adult mice is physiologically tolerated but markedly increases susceptibility to LPS-induced endotoxic shock. Endothelial-specific deletion recapitulates the phenotype, and combined caspase-8/RIPK3 deficiency rescues it, implicating extrinsic cell death pathways.
Key Findings
- Systemic PI3K-C2α inactivation in adult mice is well tolerated under baseline conditions.
- PI3K-C2α inactivation markedly sensitizes mice to LPS-induced endotoxic shock.
- Endothelial-specific PI3K-C2α deletion reproduces LPS sensitization.
- Caspase-8 and RIPK3 double deficiency rescues LPS sensitization, implicating extrinsic cell death pathways.
Clinical Implications
While not immediately practice-changing, findings caution against indiscriminate systemic PI3K-C2α inhibition in patients at risk of infection and highlight extrinsic apoptosis/necroptosis as potential therapeutic nodes in septic shock.
Why It Matters
This mechanistic discovery identifies PI3K-C2α as a gatekeeper of extrinsic cell death in endotoxemia, with implications for the safety of emerging PI3K-C2α inhibitors and for therapeutic modulation of cell death in sepsis.
Limitations
- Findings are from murine models (endotoxic shock), which may not fully capture human sepsis complexity
- Lack of direct testing in infectious sepsis models and absence of human interventional data
Future Directions
Evaluate PI3K-C2α modulation in infectious sepsis models, define endothelial signaling downstream of PI3K-C2α, and assess safety of PI3K-C2α inhibitors in infection-prone settings.
Study Information
- Study Type
- Cohort
- Research Domain
- Pathophysiology
- Evidence Level
- V - Preclinical mechanistic study in murine models with genetic perturbations
- Study Design
- OTHER